KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)

KMPHARMACEUTICAL Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	993.15	221.05	953.37	447.75	2,131	5,727
Short-Term Investments	-	-	70.5	150	235	90
Trading Asset Securities	31.83	588.92	-	-	330.1	61.67
Cash & Short-Term Investments	1,025	809.97	1,024	597.75	2,697	5,879
Cash Growth	219.06%	-20.89%	71.29%	-77.83%	-54.13%	293.63%
Accounts Receivable	1,761	1,235	1,594	2,260	3,577	2,609
Other Receivables	187.43	85.26	739.44	14.15	175.58	226.82
Receivables	1,948	1,321	2,333	2,274	3,753	2,836
Inventory	2,600	2,424	2,385	2,453	2,759	3,123
Prepaid Expenses	191.92	140.81	202.27	256.78	591.69	175.83
Other Current Assets	19.61	21.55	37.19	763.4	45.81	93.92
Total Current Assets	5,785	4,717	5,982	6,345	9,846	12,107
Property, Plant & Equipment	20,851	21,096	21,183	22,325	25,009	26,963
Long-Term Investments	7,288	7,417	5,503	4,648	4,202	4,871
Other Intangible Assets	16.93	14.24	29.41	67.68	105.7	144.09
Long-Term Deferred Tax Assets	-	-	775.7	1,258	720.28	728.77
Other Long-Term Assets	7,283	7,305	8,220	8,307	7,794	5,426
Total Assets	49,579	48,973	50,555	51,281	52,676	50,240
Accounts Payable	1,629	998.73	802.07	636.39	1,269	743.27
Accrued Expenses	1,123	856.86	1,275	603.13	898.07	694.09
Short-Term Debt	4,700	4,000	6,000	2,500	1,000	1,000
Current Portion of Long-Term Debt	3,068	3,136	3,272	8,272	3,367	272
Current Portion of Leases	-	-	39.08	51.69	51.69	51.69
Current Income Taxes Payable	-	-	-	-	26.12	7.38
Current Unearned Revenue	10.86	14.62	0.58	12.57	32.51	9.12
Other Current Liabilities	220.07	309.97	493.55	422.68	828.16	330.45
Total Current Liabilities	10,751	9,316	11,882	12,498	7,473	3,108
Long-Term Debt	7,000	7,000	3,136	2,408	5,180	6,047
Long-Term Leases	-	-	-	36.58	82.62	125.72
Other Long-Term Liabilities	37.43	41.94	59.08	10.15	34.32	185.7
Total Liabilities	17,789	16,358	15,077	14,953	12,770	9,466
Common Stock	2,789	2,789	2,789	2,789	2,789	2,789
Additional Paid-In Capital	10,911	42,562	42,562	42,562	42,562	42,562
Retained Earnings	16,792	-14,035	-9,462	-8,142	-4,217	-3,606
Treasury Stock	-0.17	-0.17	-0.17	-0.17	-0.17	-0.17
Comprehensive Income & Other	1,299	1,299	-410.63	-881.32	-1,228	-971.63
Shareholders' Equity	31,791	32,615	35,479	36,328	39,906	40,774
Total Liabilities & Equity	49,579	48,973	50,555	51,281	52,676	50,240
Total Debt	14,768	14,136	12,447	13,268	9,681	7,496
Net Cash (Debt)	-13,743	-13,326	-11,423	-12,671	-6,985	-1,618
Net Cash Per Share	-489.66	-477.86	-406.72	-455.17	-251.42	-75.58
Filing Date Shares Outstanding	27.89	27.89	27.89	27.89	27.89	27.89
Total Common Shares Outstanding	27.89	27.89	27.89	27.89	27.89	27.89
Working Capital	-4,966	-4,599	-5,900	-6,153	2,373	8,999
Book Value Per Share	1139.99	1169.54	1272.23	1302.68	1430.99	1462.11
Tangible Book Value	31,774	32,601	35,449	36,260	39,800	40,630
Tangible Book Value Per Share	1139.38	1169.03	1271.17	1300.26	1427.20	1456.94
Land	13,707	13,707	12,985	12,985	13,045	15,512
Buildings	6,516	6,516	6,374	6,374	6,886	6,839
Machinery	6,013	6,013	5,883	5,936	6,736	5,339
Construction In Progress	125.73	96.25	15.28	11.53	12.52	322.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.